Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology
Borbath, I., Ceratti, A., Verslype, C., Demols, A., Delaunoit, T., Laurent, S., Deleporte, A., Vergauwe, P., Van Maanen, A., Sempoux, C., Van Cutsem, E., Van Laethem, J.L.
Published in Annals of oncology (01.11.2013)
Published in Annals of oncology (01.11.2013)
Get full text
Journal Article
Boerhaave's syndrome: successful conservative treatment in two patients
Truyens, M, Hufkens, E, Van Geluwe, B, Vergauwe, P, Van Moerkercke, W
Published in Acta gastro-enterologica belgica (01.10.2020)
Get more information
Published in Acta gastro-enterologica belgica (01.10.2020)
Journal Article
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
Köhne, C.-H., De Greve, J., Hartmann, J. T., Lang, I., Vergauwe, P., Becker, K., Braumann, D., Joosens, E., Müller, L., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Späth-Schwalbe, E., Wilke, H.-J., Bleiberg, H., Van Den Brande, J., Debois, M., Bethe, U., Van Cutsem, E.
Published in Annals of oncology (01.05.2008)
Published in Annals of oncology (01.05.2008)
Get full text
Journal Article
A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results
Chiritescu, G., Dumon, K., Mercadé, T. Macarulla, Lang, I., Vivas, C. Santos, Papai, Z., Janssens, J., Hendrickx, K., Pracht, M., Van den Eynde, M., Taïeb, J., Moons, V., Geboes, K., Van Laethem, J., Greil, R., Cervantes, A., Vergauwe, P., Ferrante, M., Vanderstraeten, E., Fridrik, M., Wöll, E., Limón, M., Rivera, F., Sagaert, X., Tejpar, S., Van Cutsem, E.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis
D'Haens, G R, Kovács, A, Vergauwe, P, Nagy, F, Molnár, T, Bouhnik, Y, Weiss, W, Brunner, H, Lavergne-Slove, A, Binelli, D, Di Stefano, A F D, Marteau, P
Published in Journal of Crohn's and colitis (01.06.2010)
Published in Journal of Crohn's and colitis (01.06.2010)
Get full text
Journal Article
PD-0568 PHASE II STUDY OF NEO ADJUVANT TREATMENT WITH AVASTIN, XELODA AND ELOXATIN IN RECTAL CANCER (AXE BEAM)
Debucquoy, A, Verstraete, M, Chiritescu, G, Dumon, K, Vergauwe, P, Machiels, J.P, Penninckx, F, Sagaert, X, Van Cutsem, E, Haustermans, K
Published in Radiotherapy and oncology (01.05.2012)
Published in Radiotherapy and oncology (01.05.2012)
Get full text
Journal Article
A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer
Bleiberg, H, Vandebroek, A, Deleu, I, Vergauwe, P, Rezaei Kalantari, H, D'Haens, G, Paesmans, M, Peeters, M, Efira, A, Humblet, Y
Published in Acta gastro-enterologica belgica (01.03.2012)
Get more information
Published in Acta gastro-enterologica belgica (01.03.2012)
Journal Article
Azathioprine induced colitis: a case report and review of the literature
Bossuyt, P, Vergauwe, P, Inderadjaja, N, Vermeire, S
Published in Acta gastro-enterologica belgica (01.07.2007)
Get more information
Published in Acta gastro-enterologica belgica (01.07.2007)
Journal Article
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
Eng, Cathy, Kim, Tae Won, Bendell, Johanna, Argilés, Guillem, Tebbutt, Niall C, Di Bartolomeo, Maria, Falcone, Alfredo, Fakih, Marwan, Kozloff, Mark, Segal, Neil H, Sobrero, Alberto, Yan, Yibing, Chang, Ilsung, Uyei, Anne, Roberts, Louise, Ciardiello, Fortunato, Ahn, JB, Asselah, J, Badarinath, S, Baijal, S, Begbie, S, Berry, S, Canon, JL, Carbone, RG, Cervantes, A, Cha, YJ, Chang, K, Chaudhry, A, Chmielowska, E, Cho, SH, Chu, D, Couture, F, Cultrera, J, Cunningham, D, Van Cutsem, E, Cuyle, PJ, Davies, J, Dowden, S, Dvorkin, M, Ganju, V, Garcia, RV, Kerr, R, Kim, TY, King, K, Kortmansky, J, Kozloff, M, Lam, KO, Lee, J, Lee, AS, Lesperance, B, Luppi, G, Ma, B, Maiello, E, Mandanas, R, Marshall, J, Marx, G, Mullamitha, S, Nechaeva, M, Park, JO, Pavlakis, N, Ponce, CG, Potemski, P, Raouf, S, Reeves, J, Segal, N, Siena, S, Smolin, A, Streb, JO, Strickland, A, Szutowicz-Zielinska, E, Tabernero, JM, Tan, B, Valera, JS, Van den Eynde, M, Vergauwe, P, Vickers, M, Womack, M, Wroblewska, M, Young, R
Published in The lancet oncology (01.06.2019)
Published in The lancet oncology (01.06.2019)
Get full text
Journal Article
LBA2 Interim efficacy analysis of REGINA, a phase II trial of neoadjuvant regorafenib (Rego), nivolumab (Nivo), and short-course radiotherapy (SCRT) in stage II-III rectal cancer (RC)
Sclafani, F., Bregni, G., Assaf, I., Puleo, F., Vergauwe, P., Prenen, H., Diaz, M., Gokburun, Y., Sanchez, A. Veron, Anthoine, G., Moretti, L., Gomez Galdon, M., Liberale, G., Martinive, P., Geboes, K., Carrasco, J., van den Eynde, M., Laethem, J-L. van, Buyse, M.E., Hendlisz, A.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
P-276 Sex and regorafenib toxicity in refractory colorectal cancer: A safety analysis of the RegARd-C trial
Vandeputte, C., Bregni, G., Paraskevas, G., Guiot, T., Kehagias, P., Deleporte, A., Geboes, K., Delaunoit, T., Demolin, G., Peeters, M., D'Hondt, L., Janssens, J., Carrasco, J., Holbrechts, S., Goeminne, J., Vergauwe, P., Van Laethem, J., Flamen, P., Hendlisz, A., Sclafani, F.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
505TiP REGINA: A phase II trial of neoadjuvant regorafenib (rego) in combination with nivolumab (nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC)
Bregni, G., Senti, C., Reina, E. Acedo, Gkolfakis, P., Moretti, L., Veron, A., Demetter, P., Liberale, G., Carrasco, J., Geboes, K., Gokburun, Y., Peeters, M., Van den Eynde, M., Laethem, J-L. van, Vergauwe, P., Buyse, M.E., Deleporte, A., Hendlisz, A., Sclafani, F.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
449P Randomized phase II study comparing pathological responses of resected colorectal cancer metastases (CRCM) after bevacizumab (BEV) with FOLFOX or FOLFIRI (BEV-ONCO trial)
Baldin, P., Beniuga, G., Jouret-Mourin, A., Demolin, G., Roland, S., D'Hondt, L.A., Vergauwe, P., Vandaele, D., Mailleux, M., Sinapi, I., De Cuyper, A., Bletard, N., Massart, B., Delos, M., Castella, M-L., van Maanen, A., Carrasco, J., van den Eynde, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results
Chiritescu, G, Dumon, K, Mercadé, T Macarulla, Lang, I, Vivas, C Santos, Papai, Z, Janssens, J, Hendrickx, K, Pracht, M, Van den Eynde, M, Taïeb, J, Moons, V, Geboes, K, Van Laethem, J, Greil, R, Cervantes, A, Vergauwe, P, Ferrante, M, Vanderstraeten, E, Fridrik, M, Wöll, E, Limón, M, Rivera, F, Sagaert, X, Tejpar, S, Van Cutsem, E
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
AVAPLUS: Impact of geriatric assessment on first-line treatment duration (TD) and progression free survival (PFS) in mCRC patients ≥ 70 years
Decoster, L., Kenis, C., Naessens, B., Houbiers, G., De Man, M., Lambecht, G., Monsaert, E., Moons, V., Vergauwe, P., Prenen, H., Van Cutsem, E., Beutels, E., Frijns, D., Wildiers, H.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
PD-030Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years
Van Cutsem, E., Decoster, L., Houbiers, G., Naessens, B., De Man, M., Lambrecht, G., Monsaert, E., Moons, V., Vergauwe, P., Kenis, C., Wildiers, H., Opstaele, L., Van De Walle, E., Prenen, H.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
PD-030 Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years
Van Cutsem, E., Decoster, L., Houbiers, G., Naessens, B., De Man, M., Lambrecht, G., Monsaert, E., Moons, V., Vergauwe, P., Kenis, C., Wildiers, H., Opstaele, L., Van De Walle, E., Prenen, H.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
PD-030Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's greater than or equal to 70 years
Van Cutsem, E, Decoster, L, Houbiers, G, Naessens, B, De Man, M, Lambrecht, G, Monsaert, E, Moons, V, Vergauwe, P, Kenis, C, Wildiers, H, Opstaele, L, Van De Walle, E, Prenen, H
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article